Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q4 2019 · 10-K
Revenue—
Net Income-$3.60M-$3.60MN/M vs Q4 2018 EPS Diluted-$0.08-$0.08N/M vs Q4 2018 Operating Incomederived-$3,658,052N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
Operating Cash Flowderived
Free Cash Flowderived-$3,950,375N/M ended Dec 31, 2019 · filed Mar 4, 2020 · 64 d after period end